Policy Briefings

AGC Biologics Secures Anvisa GMP Certification for Seattle Facility

Cellares Collaborates With Stanford to Automate Gene-Edited HSC Manufacturing

Adragos Pharma Secures Swissmedic Approval for Beta Line Sterile Suite

WuXi Biologics Signs Trispecific TCE Agreement With Vertex Pharmaceuticals

Piramal Pharma Solutions Commercialises Tablet-in-Capsule Technology in India

Frontage Laboratories Expands Early Phase Clinical Capabilities in US and China

I Peace, Inc. Develops NKT Cell–Derived Human iPS Cells for Research Use

Aspire Biopharma Enters CDMO Agreement With Microsize for Sublingual Aspirin Development

WuXi Biologics Partners With Sinorda Biomedicine on Bispecific Antibody for IBD

Northway Biotech Joins Lithuanian–MIT Consortium to Strengthen Life Sciences Collaboration

Vetter to Build Commercial Injectable Manufacturing Plant in Saarlouis

Ardena Completes Divestment of Södertälje API CDMO to Nanologica

ExpreS2ion Selects Northway Biotech as CDMO for Nipah Vaccine

Mabtech Partners with Sai Life Sciences to Establish EYRA US Hub in Boston

Samsung Biologics Earns EcoVadis Platinum Sustainability Rating

Cellares Raises $257M Series D to Expand Global Cell Therapy IDMO Network

Lonza Reports CHF 6.5bn Sales in FY 2025, Raises 2026 Outlook

Frontage Europe Relocates Bioanalytical Lab to 2,500 m² Milan Facility